Viewing Study NCT00449761


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-04-20 @ 12:40 PM
Study NCT ID: NCT00449761
Status: TERMINATED
Last Update Posted: 2021-07-15
First Post: 2007-03-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLBH589B2211
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators